2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Parkin (PARK 2) Mutations in Patients with Early-Onset Parkinson’s Disease

A. Ivashynka, S. Likhachev (Minsk, Belarus)
Parkinson ‘ s disease and Peripheral Nervous System : Wax and Waning Non-motor offs and Levodopa-use Topics

s.g. echebarria mendieta (-, Spain)
Parkinson Disease-Associated Polyneuropathy: A Biomarker of Disease Severity?

M. Rosso, A. Merola, A. Romagnolo, C. Comi, A. Fasano, M. Zibetti, R. Lopez-Castellanos, D. Cocito, L. Lopiano, A. Espay (Cincinnati, OH, USA)
Parkinson Syndrome associated with inositol-1,4,5-triphosphate receptor antigen type 1 (ITPR1) antibodies

B. Wimmer, K. Fuchs, U. Bogdahn, A. Heimeroth (Regensburg, Germany)
Parkinson’s Disease and Urogenital Dysfunction

N. Sözer, M. Yenice, H. Erdogan, E. Demir, I. Yiğitbaşı, V. Tuğcu, V. Yayla (Istanbul, Turkey)
Parkinson’s disease disrupts motor skill learning that requires improvement of a speed-accuracy trade-off

C. Kim, A. Zimnik, U. Kang, P. Mazzoni (New York, NY, USA)
Parkinson’s disease in untreated Gaucher patients is associated with reduced glucosylsphingosine (Lyso-Gb1) serum levels

D. Arkadir, T. Dinur, A. Rolfs, A. Zimran (Jerusalem, Israel)
Parkinson’s disease patients with cognitive impairment more sensitive to pain?

K. Abe, K. Fukushima, K. Ando, Y. Maeda, R. Ishikura, H. Yoshikawa (Nishinomiya, Japan)
Parkinson’s disease subtypes correlate with clinical severity: a Brazilian population study

C. Batista, M. Medeiros, C. Rieder, A. Schuh (Porto Alegre, Brazil)
Parkinson’s disease and comorbidity: A US national perspective

A. Mithal, B. Lingala, A. Niyazov, A. Guo, C. Marras, G. Singh (Woodside, CA, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z